Literature DB >> 10748020

Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1.

I Tcherepanova1, P Puigserver, J D Norris, B M Spiegelman, D P McDonnell.   

Abstract

A transcriptional coactivator of the peroxisome proliferator-activated receptor-gamma (PPARgamma), PPARgamma-coactivator-1(PGC-1) interacts in a constitutive manner with the hinge domain of PPARgamma and enhances its transcriptional activity. In this study we demonstrate that PGC-1 is a coactivator of estrogen receptor-alpha (ERalpha)-dependent transcriptional activity. However the mechanism by which PGC-1 interacts with ERalpha is different from that of PPARgamma. Specifically, it was determined that the carboxyl terminus of PGC-1 interacts in a ligand-independent manner with the ERalpha hinge domain. In addition, an LXXLL motif within the amino terminus of PGC-1 was shown to interact in an agonist-dependent manner with the AF2 domain within the carboxyl terminus of ERalpha. The ability of PGC-1 to associate with and potentiate the transcriptional activity of an ERalpha-AF2 mutant that is unable to interact with the p160 class of coactivators suggests that this coactivator may have a unique role in estrogen signaling. It is concluded from these studies that PGC-1 is a bona fide ERalpha coactivator, which may serve as a convergence point between PPARgamma and ERalpha signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748020     DOI: 10.1074/jbc.M001364200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor.

Authors:  D Knutti; D Kressler; A Kralli
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 2.  Mitochondria and heart failure: new insights into an energetic problem.

Authors:  L Chen; A A Knowlton
Journal:  Minerva Cardioangiol       Date:  2010-04       Impact factor: 1.347

3.  Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver.

Authors:  Thomas K Felder; Selma M Soyal; Hannes Oberkofler; Penelope Hahne; Simon Auer; Richard Weiss; Gabriele Gadermaier; Karl Miller; Franz Krempler; Harald Esterbauer; Wolfgang Patsch
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

Review 4.  PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes.

Authors:  S Soyal; F Krempler; H Oberkofler; W Patsch
Journal:  Diabetologia       Date:  2006-05-17       Impact factor: 10.122

5.  Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation.

Authors:  Catherine Teyssier; Han Ma; Roger Emter; Anastasia Kralli; Michael R Stallcup
Journal:  Genes Dev       Date:  2005-06-15       Impact factor: 11.361

Review 6.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

7.  Effect of ABCG2, PPARGC1A, OLR1 and SCD1 gene polymorphism on estimated breeding values for functional and production traits in Polish Holstein-Friesian bulls.

Authors:  J Komisarek; Z Dorynek
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

8.  Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events.

Authors:  J Svärd; F Blanco; D Nevin; D Fayne; F Mulcahy; M Hennessy; J P Spiers
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

9.  Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.

Authors:  Yuzhi Yin; Hongyan Yuan; Xiao Zeng; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 10.  Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.

Authors:  Bal Krishan Sharma; Mallikarjun Patil; Ande Satyanarayana
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.